DOI: 10.1055/s-00000167

International Journal of Angiology

References

Burstein AH, Sabbagh M, Andrews R, Valcarce C, Dunn I, Altstiel L.
Development of Azeliragon, an oral small molecule antagonist of the receptor for advanced glycation endproducts, for the potential slowing of loss of cognition in mild Alzheimer's disease.

J Prev Alzheimers Dis 2018;
5 (02) 149-154

Download Bibliographical Data

Access: